Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06936202 · ClinicalTrials.gov registry record · NA

Effects of Spirulina Supplementation on Mental Health in Healthy Adults

A NA study of Depression and Mental Acuity, sponsored by Arizona State University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06936202 is a NA study of Depression and Mental Acuity that is actively recruiting participants, run by Arizona State University. The registered enrollment target is 30 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06936202, a NA study of Depression and Mental Acuity, is actively recruiting participants, sponsored by Arizona State University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Spirulina platensis is a form of cyanobacteria, a blue-green algae, and is a superfood most known for being rich in protein, vitamins and minerals, and healthful phytochemicals. Spirulina supports brain health through neuroprotection offered by its antioxidants, anti-inflammatory properties, and hormone regulation. The aim of this study is to supplement healthy adults from a campus community with 3g of spirulina, daily, for 8 weeks to improve mood and mental acuity in comparison to receiving a placebo.

Conditions Studied

Interventions

  • OTHER Placebo
  • OTHER Spirulina capsules

Study Locations (1)

Arizona

  • 850 PBC - Phoenix

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-04-15
Est. Completion 2026-05
Phase NA

Sponsor

Arizona State University

187 total trials

What the Registry Record Tells You About NCT06936202

The ClinicalTrials.gov registry entry for NCT06936202 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06936202 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT06936202 about?

NCT06936202 is a clinical study titled "Effects of Spirulina Supplementation on Mental Health in Healthy Adults". Spirulina platensis is a form of cyanobacteria, a blue-green algae, and is a superfood most known for being rich in protein, vitamins and minerals, and healthful phytochemicals. Spirulina supports brain health through neuroprotection offered by its antioxidants, anti-inflammatory properties, and hor...

What is the current status of trial NCT06936202?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-04-15. Estimated completion is 2026-05.

What conditions does trial NCT06936202 study?

This clinical trial studies the following conditions: Depression, Mental Acuity.

What interventions are being tested in trial NCT06936202?

The interventions under investigation include: Placebo (OTHER), Spirulina capsules (OTHER).

Who is sponsoring clinical trial NCT06936202?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06936202 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.